205 related articles for article (PubMed ID: 15590956)
21. Cervical metastasis as the first manifestation of ovarian papillary serous carcinoma.
Maki C; Groen J; Delgado B; Piura B
J Obstet Gynaecol; 2010 Apr; 30(3):325-6. PubMed ID: 20373951
[No Abstract] [Full Text] [Related]
22. [Inflammatory breast metastasis from cancer of the ovary].
Fondrinier E; Dagregorio G; Verrielle V; Gamelin E
Presse Med; 1998 May 23-30; 27(19):913-4. PubMed ID: 9767856
[No Abstract] [Full Text] [Related]
23. Well-differentiated serous neoplasms of the ovary.
Longacre TA; Kempson RL; Hendrickson MR
Pathology (Phila); 1993; 1(2):255-306. PubMed ID: 9420921
[TBL] [Abstract][Full Text] [Related]
24. Borderline serous papillary tumor arising in a paraovarian cyst.
Terada T
Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):215-6. PubMed ID: 20188456
[No Abstract] [Full Text] [Related]
25. Impact of adjuvant chemotherapy and pelvic radiation on pattern of recurrence and outcome in stage I non-invasive uterine papillary serous carcinoma. A multi-institution study.
Mahdi H; Elshaikh MA; DeBenardo R; Munkarah A; Isrow D; Singh S; Waggoner S; Ali-Fehmi R; Morris RT; Harding J; Moslemi-Kebria M
Gynecol Oncol; 2015 May; 137(2):239-44. PubMed ID: 25641568
[TBL] [Abstract][Full Text] [Related]
26. Papillary serous cystadenocarcinoma of the stomach, peritoneum and ovary.
Yen CC; Tsai CS; Hsi SC; Yang YS
Acta Gastroenterol Belg; 2009; 72(4):462. PubMed ID: 20163045
[No Abstract] [Full Text] [Related]
27. Low-grade ovarian cancer in an adolescent patient.
Parker LP; Ramirez PT; Broaddus R; Sightler S; Wolf JK
Gynecol Oncol; 2001 Jan; 80(1):104-6. PubMed ID: 11136580
[TBL] [Abstract][Full Text] [Related]
28. Prognosis and prognostic factors of the micropapillary pattern in patients treated for stage II and III serous borderline tumors of the ovary.
Uzan C; Kane A; Rey A; Gouy S; Camatte S; Pautier P; Lhommé C; Haie-Meder C; Duvillard P; Morice P
Oncologist; 2011; 16(2):189-96. PubMed ID: 21273510
[TBL] [Abstract][Full Text] [Related]
29. [The dilemma of 'the final laparotomy'].
Lammes FB
Ned Tijdschr Geneeskd; 1995 Jun; 139(23):1161-3. PubMed ID: 7791919
[No Abstract] [Full Text] [Related]
30. Pilot phase II trial of radiation "sandwiched" between combination paclitaxel/platinum chemotherapy in patients with uterine papillary serous carcinoma (UPSC).
Fields AL; Einstein MH; Novetsky AP; Gebb J; Goldberg GL
Gynecol Oncol; 2008 Jan; 108(1):201-6. PubMed ID: 17997145
[TBL] [Abstract][Full Text] [Related]
31. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 10-1995. A 56-year-old woman with abdominal pain, anemia, and a pelvic mass.
N Engl J Med; 1995 Mar; 332(13):876-81. PubMed ID: 7870144
[No Abstract] [Full Text] [Related]
32. [Normal-sized ovary carcinoma syndrome--clinical and pathological analysis of 11 cases].
Yao Z; Li L; Yang H
Zhonghua Zhong Liu Za Zhi; 1998 Sep; 20(5):383-6. PubMed ID: 10921039
[TBL] [Abstract][Full Text] [Related]
33. Ovarian serous borderline tumors with noninvasive and invasive peritoneal implants: A case report each.
Srinivasamurthy BC; Kulandai Velu AR; Krishnan N; Patil AS
J Cancer Res Ther; 2015; 11(3):646. PubMed ID: 26458602
[TBL] [Abstract][Full Text] [Related]
34. Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy.
Kelly MG; O'malley DM; Hui P; McAlpine J; Yu H; Rutherford TJ; Azodi M; Schwartz PE
Gynecol Oncol; 2005 Sep; 98(3):353-9. PubMed ID: 16005947
[TBL] [Abstract][Full Text] [Related]
35. Ovarian serous surface papillary borderline tumors form sea anemone-like masses.
Tanaka YO; Okada S; Satoh T; Matsumoto K; Oki A; Nishida M; Yoshikawa H; Saida T; Minami M
J Magn Reson Imaging; 2011 Mar; 33(3):633-40. PubMed ID: 21287653
[TBL] [Abstract][Full Text] [Related]
36. Stage III papillary serous cystadenocarcinoma of the ovary in a 15-year-old female.
Moen MD; Cliby WA; Wilson TO
Gynecol Oncol; 1994 May; 53(2):274-6. PubMed ID: 8188094
[TBL] [Abstract][Full Text] [Related]
37. Serous psammocarcinoma of the ovary.
Powell JL; McDonald TJ; White WC
South Med J; 1998 May; 91(5):477-80. PubMed ID: 9598860
[TBL] [Abstract][Full Text] [Related]
38. Prospective, non-randomized phase 2 clinical trial of carboplatin plus paclitaxel with sequential radical pelvic radiotherapy for uterine papillary serous carcinoma.
Obermair A; Mileshkin L; Bolz K; Kondalsamy-Chennakesavan S; Cheuk R; Vasey P; Wyld D; Goh J; Nicklin JL; Perrin LC; Sykes P; Janda M
Gynecol Oncol; 2011 Feb; 120(2):179-84. PubMed ID: 21126755
[TBL] [Abstract][Full Text] [Related]
39. The effect of adjuvant chemotherapy versus whole abdominopelvic radiation on the survival of patients with advanced stage uterine papillary serous carcinoma.
Hamilton CA; Cheung MK; Osann K; Balzer B; Berman ML; Husain A; Teng NN; Kapp DS; Chan JK
Gynecol Oncol; 2006 Nov; 103(2):679-83. PubMed ID: 16793126
[TBL] [Abstract][Full Text] [Related]
40. Cytologic findings of psammocarcinoma in peritoneal washings.
Pantanowitz L; Otis CN; Goulart RA
Acta Cytol; 2009; 53(3):263-7. PubMed ID: 19534264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
